Latest Sedatives Stories
TEL AVIV, Israel, July 5, 2010 /PRNewswire/ -- Neurim Pharmaceuticals (http://www.Neurim.com) confirmed today that the European Commission (EC) has approved a change in treatment duration with Circadin from 3 to 13 weeks (3 months).
When seizures strike, the most immediate goal for caregivers is to get appropriate medication to the patient as quickly as possible to stop the seizing activity.
Individuals with chronic insomnia have an elevated risk of death.
WASHINGTON, April 27 /PRNewswire-USNewswire/ -- AstraZeneca LP and AstraZeneca Pharmaceuticals LP will pay $520 million to resolve allegations that AstraZeneca illegally marketed the anti-psychotic drug Seroquel for uses not approved as safe and effective by the Food and Drug Administration (FDA), the Departments of Justice and Health and Human Services' Health Care Fraud Enforcement Action Team (HEAT) announced today.
NORTH KINGSTOWN, R.I., April 15 /PRNewswire/ -- Unintentional poisoning deaths have dramatically increased over the last decade to become the second leading cause of injury deaths in the United States.
FORT LEE, N.J., March 10 /PRNewswire/ -- Dainippon Sumitomo Pharma America, Inc. (DSPA), a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP), today announced that the U.S.
The UNâ€™s top global drug regulator said on Wednesday that more people are turning to prescription drug abuse than cocaine, heroin and ecstasy combined.
POINT RICHMOND, Calif., Feb. 22 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) announced today an update on its plans to seek U.S.
Scientists announced Wednesday they have solved the mystery behind why people become addicted to a class of prescription drugs that includes some anti-depressants, muscle relaxants and sleeping pills.
POINT RICHMOND, Calif., Feb. 9 /PRNewswire-FirstCall/ --Transcept Pharmaceuticals, Inc.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.